These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 2050399

  • 1. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide.
    Paton JC, Lock RA, Lee CJ, Li JP, Berry AM, Mitchell TJ, Andrew PW, Hansman D, Boulnois GJ.
    Infect Immun; 1991 Jul; 59(7):2297-304. PubMed ID: 2050399
    [Abstract] [Full Text] [Related]

  • 2. Protective immunity and gene expression related to pneumococcal glycoconjugate.
    Lee CJ, Li ZM.
    Adv Exp Med Biol; 2001 Jul; 491():505-14. PubMed ID: 14533818
    [Abstract] [Full Text] [Related]

  • 3. Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide--pneumolysoid conjugate.
    Lee CJ, Lock RA, Andrew PW, Mitchell TJ, Hansman D, Paton JC.
    Vaccine; 1994 Aug; 12(10):875-8. PubMed ID: 7975828
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneumoniae.
    Ferreira DM, Arêas AP, Darrieux M, Leite LC, Miyaji EN.
    FEMS Immunol Med Microbiol; 2006 Mar; 46(2):291-7. PubMed ID: 16487311
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines.
    Kuo J, Douglas M, Ree HK, Lindberg AA.
    Infect Immun; 1995 Jul; 63(7):2706-13. PubMed ID: 7790088
    [Abstract] [Full Text] [Related]

  • 7. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV.
    Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J, Alderson M, Tate A, Hollingshead SK, Tweten RK, Briles DE, Tuomanen EI, Paton JC.
    Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae.
    Lock RA, Hansman D, Paton JC.
    Microb Pathog; 1992 Feb; 12(2):137-43. PubMed ID: 1350045
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.
    Ogunniyi AD, Folland RL, Briles DE, Hollingshead SK, Paton JC.
    Infect Immun; 2000 May; 68(5):3028-33. PubMed ID: 10769009
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
    Sorensen RU, Leiva LE, Giangrosso PA, Butler B, Javier FC, Sacerdote DM, Bradford N, Moore C.
    Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341
    [Abstract] [Full Text] [Related]

  • 19. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.
    Giebink GS, Koskela M, Vella PP, Harris M, Le CT.
    J Infect Dis; 1993 Feb; 167(2):347-55. PubMed ID: 8421168
    [Abstract] [Full Text] [Related]

  • 20. Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein.
    Michon F, Fusco PC, Minetti CA, Laude-Sharp M, Uitz C, Huang CH, D'Ambra AJ, Moore S, Remeta DP, Heron I, Blake MS.
    Vaccine; 1998 Nov; 16(18):1732-41. PubMed ID: 9778749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.